Comparison of Real-Time PCR and Immunohistochemistry for HER-2/neu gene amplification assay in breast cancer tissue

Authors

Ahmad Kaviani1, Rezvan Esmaeili2, Mohsen Foroughizadeh Moghaddam3, Nasrin Abdoli4, Ali-Akbar Zare4, Mohammad Hossein Lashgari5, Keivan Majidzadeh6,*
1Associated professor, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Andorra
2Researcher, Cancer Genetics Research Group, Breast Cancer Research Center (BCRC), ACECR, Tehran, Iran, Andorra
3Researcher, Novin medical radiation institute, Tehran, Iran, Andorra
4- Researcher, Cancer Genetics Research Group, Breast Cancer Research Center (BCRC), ACECR, Tehran, Iran, Andorra
5- Assistant Professor, Department of Surgery, AJA University of Medical Science, Tehran, Iran, Andorra
6Associated professor, Faculty of Medicine, AJA University of Medical Science, Tehran, Iran and Associated professor, Cancer Genetics Research Group, Breast Cancer Research Center (BCRC), ACECR, Tehran, Iran., Andorra
*Corresponding Author: Corresponding author: Keivan Majidzadeh, Associated professor, Faculty of Medicine, AJA University of Medical Science, Tehran, Iran and Associated professor, Cancer Genetics Research Group, Breast Cancer Research Center (BCRC), ACECR, Tehran, Iran., Andorra Email: [email protected]

Annals of Military and Health Sciences Research:Vol. 11, issue 3; e65138
Published online:Sep 18, 2013
Article type:Research Article
Received:May 29, 2013
Accepted:Aug 18, 2013
How to Cite:Kaviani A, Esmaeili R, Foroughizadeh Moghaddam M, Abdoli N, Zare A, et al. Comparison of Real-Time PCR and Immunohistochemistry for HER-2/neu gene amplification assay in breast cancer tissue. Ann Mil Health Sci Res. 2013;11(3):e65138. doi:

Abstract

Background: HER-2/neu is one of the major molecular prognostic markers in breast cancer and due to treatment decision guidelines, the amplification of this gene is very important in breast cancer patients treatment. The most commonly used method for detecting HER-2/neu gene amplification is immunohistochemistry (IHC). Unquantifiable results, lack of reproducibility and long procedure time are among the drawbacks of this method which have persuaded researchers to seek alternative modern molecular based techniques such as Real-Time PCR. The aim of our study was the comparison of HER-2 gene amplification assessed by RealTime PCR and IHC method. Materials and Methods: After DNA extraction, 41 formalin-fixed paraffin-embedded (FFPE) breast carcinoma with known IHC results, had been assessed using Real-Time PCR and gene copy number of HER-2 were measured and compared with the results of IHC. Fluorescent in situ hybridization (FISH) for equivocal IHC and unreliable results were performed. The Fisher's Exact Test and Phi Cramer's V Coefficient were used for statistical analysis. Results: According to the results, 39% of samples tested by Real-Time PCR have HER-2/neu gene amplification and 36% of samples was positive by IHC. The correlation of two methods in positive and negative samples were 85% and 87% respectively. Overrall correlation between two methods was 71%. Also, IHC2+ results have been assessed by FISH technique and all of them were negative, which was in concordance with the results of the Real-Time PCR. Conclusion: About 71% concordance had been observed between two methods. In the case of IHC2+ results, FISH was performed and proved the Real-Time PCR results. Real-Time PCR could precisely measure the amount of tissue HER2 amplification and also were in agreement with IHC results. Since Real-Time PCR has high precision, also is cheaper and more accessible than other methods, we suggest it to be used to assess this indicator.

Fulltext

Full text is available in pdf

References

  • 1.
    References are available in pdf.

Copyright

© 2013, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

13
Jul
2019
Investigation of Equivocal Expression of HER2 Gene by Immunohistochemistry in Patients with Invasive Breast Ductal Cancer Confirmed by CISH or FISH and Its Relationship with Clinicopathologic Variables

Investigation of Equivocal Expression of HER2 Gene by Immunohistochemistry in Patients with Invasive Breast Ductal Cancer Confirmed by CISH or FISH and Its Relationship with Clinicopathologic Variables

Fariba Binesh,
Amirmasoud Homayon,
Hassanali Vahedian Ardekani,
Sedighe Vaziribozorg,
Seyed Hossein Shahcheraghi

Binesh F, Homayon A, Vahedian Ardekani H, Vaziribozorg S, Shahcheraghi SH. Investigation of Equivocal Expression of HER2 Gene by Immunohistochemistry in Patients with Invasive Breast Ductal Cancer Confirmed by CISH or FISH and Its Relationship with Clinicopathologic Variables. Jentashapir J Cell Mol Biol. 2019;9(6):e89002. doi: https://doi.org/10.5812/jjhr.89002

19
Sep
2022
Detection and Genotyping of Papillomavirus by Real-Time PCR in Iraqi Patients

Detection and Genotyping of Papillomavirus by Real-Time PCR in Iraqi Patients

Zeina S M Al-Hadeithi,
Saade Abdalkareem Jasim,
Omar Dheyauldeen Salahldina

Al-Hadeithi ZSM, Jasim SA, Salahldina OD. Detection and Genotyping of Papillomavirus by Real-Time PCR in Iraqi Patients. Arch Clin Infect Dis. 2022;17(3):e121143. doi: https://doi.org/10.5812/archcid-121143

30
Sep
2017

A review on different types of Real-time PCR methods and its optimization

Mohsen Keshavarz,
Ahmad Tavakoli,
Hossein Keyvani,
Mohammad Hadi Karbalaie Niya

Keshavarz M, Tavakoli A, Keyvani H, Karbalaie Niya MH. A review on different types of Real-time PCR methods and its optimization. J Inflamm Dis. 2024;21(3):e156033. doi:

30
Sep
2020
Accuracy of Digital Image Analysis (DIA) of Borderline Human Epidermal Growth Factor Receptor (HER2) Immunohistochemistry in Invasive Ductal Carcinoma

Accuracy of Digital Image Analysis (DIA) of Borderline Human Epidermal Growth Factor Receptor (HER2) Immunohistochemistry in Invasive Ductal Carcinoma

Nema Mohamadian Roshan,
Sepideh Salehabadi,
Melika Kooshki Forooshani,
Azin Nikoozadeh

Mohamadian Roshan N, Salehabadi S, Kooshki Forooshani M, Nikoozadeh A. Accuracy of Digital Image Analysis (DIA) of Borderline Human Epidermal Growth Factor Receptor (HER2) Immunohistochemistry in Invasive Ductal Carcinoma. Int J Cancer Manag. 2020;13(9):e101179. doi: https://doi.org/10.5812/ijcm.101179

6
May
2017

Immunohistochemical Study of HER2/neu Expression in Colorectal Cancer and its Relation to other Clinicopathological Criteria and Prognostic Factors

Nesa Sayadnejad,
Alireza Firouzjahi,
Shahryar Shafaee,
Hannaneh Golshahi,
Zahra Sokouti,
Hemmat Gholinia
,et al.

Sayadnejad N, Firouzjahi A, Shafaee S, Golshahi H, Sokouti Z, et al. Immunohistochemical Study of HER2/neu Expression in Colorectal Cancer and its Relation to other Clinicopathological Criteria and Prognostic Factors. Int J Cancer Manag. 2017;10(5):e5700. doi: https://doi.org/10.5812/ijcm.5700

More by these authors

Ahmad KavianiPubMedScholar
Rezvan EsmaeiliPubMedScholar
Mohsen Foroughizadeh MoghaddamPubMedScholar
Nasrin AbdoliPubMedScholar
Ali-Akbar ZarePubMedScholar
Mohammad Hossein LashgariPubMedScholar
Keivan MajidzadehPubMedScholar
Share
Cited by
Metrics